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Mutations in SCO2 Are Associated
with Autosomal-Dominant High-Grade Myopia
Khanh-Nhat Tran-Viet,1 Caldwell Powell,1 Veluchamy A. Barathi,2,3,4 Thomas Klemm,2
Sebastian Maurer-Stroh,5,6 Vachiranee Limviphuvadh,5,6 Vincent Soler,7 Candice Ho,3
Tammy Yanovitch,8 Georg Schneider,5,9 Yi-Ju Li,1,2,10,13 Erica Nading,1,11 Ravikanth Metlapally,12
Seang-Mei Saw,13 Liang Goh,2,13 Steve Rozen,2 and Terri L. Young1,2,11,13,*
Myopia, or near-sightedness, is an ocular refractive error of unfocused image quality in front of the retinal plane. Individuals with high-
grade myopia (dioptric power greater than 6.00) are predisposed to ocular morbidities such as glaucoma, retinal detachment, and
myopic maculopathy. Nonsyndromic, high-grade myopia is highly heritable, and to date multiple gene loci have been reported.We per-
formed exome sequencing in 4 individuals from an 11-member family of European descent from the United States. Affected individuals
had a mean dioptric spherical equivalent of 22.00 sphere. A premature stop codon mutation c.157C>T (p.Gln53*) cosegregating with
disease was discovered within SCO2 that maps to chromosome 22q13.33. Subsequent analyses identified three additional mutations
in three highly myopic unrelated individuals (c.341G>A, c.418G>A, and c.776C>T). To determine differential gene expression in a
developmental mouse model, we induced myopia by applying a 15.00D lens over one eye. Messenger RNA levels of SCO2 were sig-
nificantly downregulated in myopic mouse retinae. Immunohistochemistry in mouse eyes confirmed SCO2 protein localization in
retina, retinal pigment epithelium, and sclera. SCO2 encodes for a copper homeostasis protein influential in mitochondrial
cytochrome c oxidase activity. Copper deficiencies have been linked with photoreceptor loss andmyopia with increased scleral wall elas-
ticity. Retinal thinning has been reported with an SC02 variant. Human mutation identification with support from an induced myopic
animal provides biological insights of myopic development.Myopia is a common ocular disorder primarily resulting
from globe axial elongation.1,2 Its extreme form, high-
grade myopia (refractive error greater than 6.00 diopters
[D]) (MIM 160700, MIM 613969, MIM 60995, MIM
608367, MIM 614167, MIM 603221, MIM 608474, MIM
612554, and MIM 609994), is highly heritable and associ-
ated with ocular morbidities such as retinal detachment,
maculopathy, cataracts, and glaucoma.3 Myopia preva-
lence rates vary worldwide. The highest prevalence rates
are those in Asian countries, particularly in urban settings.
Over 80% of school children in Taiwan develop myopia
by adulthood, and similar rates are seen in children aged
between 13 and 15 years in Hong Kong.4–6 In the United
States, 33.1% of adults have some degree of myopia,
and high-grade myopia affects approximately 2% of the
myopic population.7,8 The economic impact of refractive
error management is substantial. In the U.S., adults
spend an average of $199 annually on refractive-error-
correction-related costs.9 U.S. estimates in 2007 of costs
associated with vision impairment exceeded 51 billion
dollars annually.10 In conjunction, vision-impairment
correction costs in the U.S. account for $3.8 to $7.2 billion
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have identified loci and genes associated with nonsyn-
dromic myopia.12 High-grade myopia is regarded to be
distinct from low-grade myopia, as classified through
thresholds in spherical refractive error and axial length
measurements.13 Recently, advances in deep sequencing
technology have identified mutations in genes associated
with a variety of ocular disorders including myopia.14–16
In 2011, Shi et al. identified mutations in zinc finger
protein 644 isoform 1 (ZNF644) in a Chinese family with
autosomal-dominant high-grade myopia by using exome
sequencing, which was replicated in four cases in our
European descent cohort.16,17
Herein, we describe the identification of pathogenic
mutations in the SCO2 cytochrome c oxidase (COX)
assembly protein (SCO2) on chromosome 22q13.33
(NM_001169111.1). Gene expression studies in an ex-
perimentally induced myopic mouse model suggest that
SCO2 may play a role in myopic development.
A large three-generation index family (11 members) of
European descent with nine affected individuals with
high-grade myopia (average spherical refractive error of
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Figure 1. A Family with High-Grade
Myopia
Segregation of SCO2mutation (c.157C>T)
in a high-grade myopia family. Abbrevia-
tions are as follows:þ indicates DNA avail-
able for this study, and x indicates samples
used for exome sequencing. Where avail-
able, the genotype of each individual is
shown as a ‘‘WT’’ for the wild-type allele
and as an ‘‘M’’ for the mutated allele.consent was obtained from all participants, with approval
by the Institutional Review Board according to the princi-
ples of the Declaration of Helsinki. DNA was extracted
from blood and/or saliva from all participating family
members. The affected phenotype was determined as those
with high myopia (refractive error greater than 6.00D)
with no systemic abnormalities. To identify the genetic eti-
ology of disease in our family, we employed exome
sequencing. We selected four individuals (III:1, III:2, IV:1,
IV:2) for sequencing and analysis (Figure 1). An additional
60 ethnically matched exomes and 1,172 ethnically
matched controls (500 samples ascertained internally,
and 672 samples purchased commercially; The Centre for
Applied Genomics, The Hospital for Sick Children, Tor-
onto, Canada) were available for subsequent validation
studies to analyze allelic frequencies for candidate variants.
Exome sequencing was performed by Beijing Genomics
Institute (BGI), and data analyses were conducted inter-
nally. Seven micrograms (mg) of DNA were submitted
with independent sample processing by using the Agilent
SureSelect XT Human All Exon 38 Mb kit (Agilent, Santa
Clara, CA). High throughput sequencing was performed
with 91 base pair (bp) paired-end runs on a HiSeq2000
(Illumina, San Diego, CA). Read alignment was conducted
by using Burrows-Wheeler Aligner (v.0.5.6) and potential
duplicate reads were removed with Picard v.1.40.18
Filtering and detection of reads were conducted by usingThe American Journal of HumaSAMtools (v.0.1.7).19 Single nucleo-
tide variants and microindels were
annotated by using the Genome
Analyzer Toolkit (GATK- v1.4). We
generated an average of 37.8 giga-
bases (Gb) of sequence and coverage
of 343 for each individual. An
average of 95.7% of targeted bases
was covered in the four subject sam-
ples, and 87.5% of the target had at
least 53 coverage (see Supplement 1
available online).
Variants in dbSNP132 with a minor
allele frequency greater than 3%
and those present in more than 1%
of public exomes (NHLBI and 1000
Genomes) were excluded. In addi-
tion, heterozygous variants present
in at least one affected individualwere kept in the finalized list. In conjunction with
filtering, Integrated Genome Viewer (IGV) visualization
software was utilized to confirm corresponding reads and
read depth to verify false positives or negatives. We identi-
fied 49 variants shared among the exome-sequenced
affected members only. To minimize false positives due
to batch effects, we verified all 49 variants as unique
in silico relative to 60 exomes previously sequenced by
our group. We performed Sanger sequencing of all 49 var-
iants and demonstrated 100% validation (49/49) in the
four index DNA samples. All microindels were eliminated
based on our filtering criteria. To confirm the segregation
of variants with the disease phenotype, we used Sanger
sequencing for the remaining 7 family member DNA
samples against all 49 variants.
A rare nonsense mutation of c.157C>T (rs74315510)
within exon 2 of SCO2 cytochrome c oxidase assembly
protein (SCO2, NM_001169111.1) segregated with high-
grademyopia in the pedigree. The SCO2mutation converts
the amino acid glutamine to a premature stop codon on
base 53 (p.Gln53*). The minor allele was not present in
1,000 control samples for the SCO2 variant. The MERLIN
program using a dominant parametric model was em-
ployed to estimate the linkage of this variant.20 A two-
point LOD score of 1.49 for c.157C>T was calculated for
the family.20 PCR sequencing of the SCO2 coding exon 2
was conducted in an additional 140 high-grade myopian Genetics 92, 820–826, May 2, 2013 821
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822 The American Journal of Human Genetics 92, 820–826, May 2, 2cases. The average spherical equivalent refraction of the
cases was 11.00D (OD) and 10.50D (OS), respectively.
We identified two additional rare variants (rs74315511
and rs8139305) and one variant in three unrelated
cases that were heterozygous (Table 1). Rs74315511
(c.418G>A) is a missense mutation predicted to cause
a p.Glu140Lys substitution. Rs8139305 (c.776C>T)
missense mutation causes a p.Ala259Val substitution.
The missense mutation (c.341G>A) causes a substitution
of p.Arg114His. These variants were not seen in the same
1,000 control DNA samples. ANNOVAR was used to assess
functional annotation and at least one in silico software
predicted the mutations to be deleterious or damaging
(Table 1).21–27 By using the Fisher exact test, the likelihood
for identifying the 4 functional variants in 141 individuals
with high-grade myopia relative to 1,000 nonmyopic
controls was significant (p ¼ 0.000248).
SCO2 consists of two exons of which only the second
exon is protein coding. Given the mutation location,
c.157C>T truncates the protein before the catalytic
domain, rendering it nonfunctional. The protein changes
(p.Arg114His, p.Glu140Lys, and p.Ala259Val) by using
BLAST are all located within the functional catalytic
domain and are predicted to affect the protein structure.
The p.Glu140Lys amino acid substitution results in
removal of a salt bridge between Glu140 and Lys143 and
changes the electrostatic potential of the copper binding
site, which can moderately to strongly affect SCO2 func-
tion (Supplements 2 and 3). Moreover, p.Arg114His and
p.Ala259Val are predicted to destabilize the structure based
on FoldX, with mild-to-moderate influence on SCO2 func-
tion (Supplement 4).28
Immunohistochemical results in mouse ocular tissues
confirmed SCO2 protein localization in the retina, retinal
pigment epithelium (RPE), and scleral wall (Figure 2). Im-
munostaining intensity was reduced significantly in
myopic retinal tissues of experimentally induced myopic
mice compared to the nonmyopic independent controls
and was significantly increased in myopic sclera (Figure 2).
Sco2 expression in ocular tissues was compared between
induced myopic mouse eyes relative to the control fellow
eye. Ocular tissues of myopic (with spherical equivalent
[SE] < 5.00D) and fellow nonoccluded eyes of the exper-
imental mice were compared with age-matched control
tissues (Supplement 6). Real-time PCR confirmed Sco2
messenger RNA (mRNA) levels to be significantly reduced
in myopic retina compared to naive control retina (fold
change [FC] ¼ 8.3, p < 0.001). Increased Sco2 mRNA
was detected in myopic compared to control sclera
(FC ¼ þ5.6, p < 0.01) (Figure 3). Reverse transcription
PCR of SCO2 expression in fetal and adult human ocular
tissues confirmed expression in the choroid, sclera, retina,
and RPE (Supplement 6).
SCO2 is a copper chaperone integral to oxygen reduc-
tion catalysis by cytochrome c oxidase of the mitochon-
drial respiratory chain.29 The COX assembly assists
in ATP metabolism, and disruptions exhibit increased013
Figure 2. Immunofluorescent Labeling
of Sco2 in Mouse Ocular Tissues in
Induced Myopic Eyes, Fellow Eyes, and
Independent Control Eyes
Immunofluorescent labeling of Sco2 in
mouse retina, retinal pigment epithelium,
and sclera in induced myopic eyes, fellow
eyes, and independent control eyes. The
florescence intensity labeled of the green
color shows the localization of proteins,
and blue color indicates the nuclei that
were stained with DAPI. Lower level of
abundance was determined for myopic
retina and RPE, whereas a higher level of
abundance was found in myopic sclera.
The following abbreviations represent the
retinal layers: NFL, nerve fiber layer; GCL,
ganglion cell layer; IPL, inner plexiform
layer; INL, inner nuclear layer; OPL, outer
plexiform layer; ONL, outer nuclear layer;
PRL, photo receptor layer; and RPE, retinal
pigment epithelium.intraocular oxygen levels and loss in protection to
increased oxygen toxicity.30 Protein deficiency can result
in reactive oxygen species increase and oxidative DNA
damage.31 COX deficiencies affect organs with high energy
demand.32 Because the retina is one of the most highly
metabolic tissues in the body, the increased oxidative stress
may alter retinal function and therefore image quality,
which is essential for refractive development.31,33–41
Normal copper metabolism is essential to ocular tissue
health and is associated with myopic refractive error devel-
opment.42–44 As an example of trace element ocular tissue
effects, copper-deficient rats exhibit a loss of conjunctival
goblet cells, decrease in conjunctival and cornealmicrovilli
and microplicae, retinal photoreceptor cell degeneration
and disappearances, and degeneration and disappearance
of myelin lamellae of myelinated optic nerve fibers.45,46
This implicates proper copper metabolism for cell differen-
tiation, development, and maintenance.46 One study
demonstrated the protective effect of copper supplements
in individuals with myopia.47 Restoration by subTenon’s
capsule injection of copper compounds resulted in
increased scleral copper concentration and improved
scleral tissue elasticity with cessation of myopic refractive
error development.47
Reduced retinal layer thickness is correlated with higher
degrees of myopia in humans with degenerative
retinal changes.16,48,49 Our experimentally induced
myopic mouse model demonstrated retinal thinning,The American Journal of Humacorroborating previous animal studies
with similar results.50,51 Tree shrews
and other animal models with experi-
mentally induced myopia demon-
strated retinal ganglion cell layer
thinning.51,52 Interestingly, the high-
ly conserved paralogous SCO1 (Sup-
plement 7) was upregulated inmyopic chick retinae induced with positive (hyperopic)
lens exposure.52
SCO2mutations are associated with autosomal-recessive
fatal infantile cardioencephalomyopathy (MIM 604377),
COX deficiency, and milder spinal muscular atrophy-like
presentations.53–57 Affected individuals harbor mutations
in a compound heterozygous state, where p.Glu140Lys
and an additional damaging substitution are typically
present.54,58 p.Glu140Lys and p.Gln53* have been re-
ported in cardiomyopathy patients, whereas p.Arg114His
and p.Ala259Val (rs8139305) are without annotation for
clinical associations.54,55 Retinal histology of a subject
with cardioencephalomyopathy harboring a compound
heterozygous substitution of p.Glu140Lys and p.Gln53*
had retinal ganglion neuronal loss and globular distension
of the retinal photoreceptors.59 Neonatal expiration
precludes investigation of an associated clinical ocular
phenotype such as refractive error. It is worth noting that
phenotype-genotype variability does occur and has been
seen in cardiovascular and ocular diseases.60,61 Within
SCO2, variability in onset and systemic involvement
have been reported between compound heterozygous
and homozygous individuals.58 Visual impairment is often
regarded as a benign disorder as a result of efficient treat-
ment options such as glasses, contact lenses, and refractive
surgery and is not always recognized as a disease pheno-
type in medical registries.62 The phenotypical intersection
of myopia and cardioencephalomyopathy presented heren Genetics 92, 820–826, May 2, 2013 823
Figure 3. Transcription Quantification of Sco2 in Mouse Retina
and Sclera in InducedMyopic Eyes, Fellow Eyes, and Independent
Control Eyes
Experimental myopia was induced in B6 wild-type (WT) mice
(n ¼ 36) by applying a 15.00 D spectacle lens on the right eye
(experimental eye) for 6 weeks since postnatal day 10. The left
eyes were uncovered and served as contra-lateral fellow eyes.
Age-matched naive mice eyes were used as independent control
eyes (n ¼ 36). Primer sequences to conduct qRT-PCR were forward
50 ATC GCA CAG CCC TAA GTC TC 30 and reverse 50 CAG TAG
CAT CGT GGA CCT GA 30 (NM_001111288.1).
The bar represents the fold changes ofmRNA for Sco2 after normal-
ization by using GAPDH as reference. The mRNA levels of sco2 in
myopic and fellow retina and sclera are compared with indepen-
dent controls. Relative fold change—the values are shown in log
values (210). n ¼ 36; *p < 0.05, **p < 0.01 and ***p < 0.001.must be considered exploratory and further studies are
warranted.
In summary, we identified four heterozygous muta-
tions—c.157C>T (p.Gln53*), c.341G>A (p.Arg114His),
c.418G>A (p.Glu140Lys), and c.776C>T (p.Ala259Val)—
in individuals and families with high-grade myopia. Inves-
tigations in silico revealed that the nonsense mutation
c.157C>T truncates the protein before the catalytic
domain, whereas the other three mutations are predicted
to destabilize the protein structure. The destabilization of
the protein may result in modulation of oxidative
toxicity—particularly in the retina, leading to retinal neu-
ronal thinning due to threshold changes in ROS.31,33–35,63
In addition, mutations can affect copper metabolism,
which may result in an imbalance of copper enzymatic
support activity and oxidative levels within eye tissues.
Refractive error genetics has proven to be complex, as
demonstrated by mapping and large association studies.
Although SCO2 did not colocalize in any reported myopia
loci, our findings provide evidence that SCO2may play an
important role in eye growth and development, particu-
larly in those who become highly myopic. A myopic
phenotype should not be overlooked in studies involving
a heterogeneous group of rare disorders involving SCO2.Supplemental Data
Supplemental Data include seven supplements and can be found
with this article online at http://www.cell.com/AJHG/.824 The American Journal of Human Genetics 92, 820–826, May 2, 2Acknowledgments
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